drugset / Trial / NCT00799071

Pharmacokinetics of Posaconazole in Children With Chronic Granulomatous Disease (CGD)

NCT00799071

Phase 2 Completed 12 enrolled Radboud University Medical Center
NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to find a dose for a twice daily regimen for posaconazole (PSZ) as prophylactic treatment in children with CGD, based on the PSZ trough level.

Timeline

Start
2009-02
Primary completion
2010-07
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Posaconazole Small molecule 40 mg/ml Oral